Sociedad Quimica Y Minera SA (QYM) Q2 2026 Earnings Report

SQM's call was largely positive: the company reported record lithium volumes, rising Q2 lithium prices, clear near-term production targets (280k–290k LCE in 2026; ~300k in 2027), robust iodine and specialty nutrition performance, and sizable strategic investments (Mount Holland expansion, Salar Futuro, and $3B CapEx plan). However, the positive outlook is tempered by market and execution risks — price volatility, timing/realization mismatches, potential supply additions from other regions, BESS deployment timing, reliance on tolling partners, and multi-year timelines for major projects — which create short-to-medium term uncertainty.

Management's guidance highlighted strong near‑term volumes and a clear build‑out of capacity: record Q2 sales of >84,000 metric tons LCE, Q3 sales volumes and index‑based prices expected roughly in line with Q2 (with Q3 unit costs similar to Q2 and gross margins broadly stable), Novandino Litio production guidance of 280,000–290,000 mt LCE in 2026 and ~300,000 mt capacity by 2027 (with roughly 80,000 mt LCE from sulfate processing and ~220,000 mt from the Antofagasta plant, and ~20–30k mt as hydroxide), International (Australia/Covalent) full‑year sales expected at ~27,000–30,000 mt LCE, SQM’s view that global lithium demand will exceed 2.1 million mt in 2026, a ~$3 billion capital expenditure program for 2026–28 (and the Salar Futuro project also described at ~ $3 billion over seven years), Mount Holland spodumene capacity to double to ~350,000 tpy with first production targeted in 2030, expected total iodine production of ~15,500 mt in 2026, specialty plant nutrition volumes up ~10% versus 2025, and >$1.6 billion paid to the Chilean government in 1H.